Chan P - Search Results

1

Response to the letter "No evidence to support high-intensity statin in Chinese patients with coronary heart disease".

Tomlinson B, Hu M, Zhang Y, Liu ZM, Chan P. Tomlinson B, et al. Among authors: chan p. Int J Cardiol. 2016 Apr 15;209:192-3. doi: 10.1016/j.ijcard.2016.02.047. Epub 2016 Feb 3. Int J Cardiol. 2016. PMID: 26896621 No abstract available.

2

Beneficial effects on blood pressure and lipid profile of programmed exercise training in subjects with white coat hypertension.

Tsai JC, Liu JC, Kao CC, Tomlinson B, Kao PF, Chen JW, Chan P. Tsai JC, et al. Among authors: chan p. Am J Hypertens. 2002 Jun;15(6):571-6. doi: 10.1016/s0895-7061(02)02273-2. Am J Hypertens. 2002. PMID: 12074361 Clinical Trial.

3

Protective effects of trilinolein extracted from panax notoginseng against cardiovascular disease.

Chan P, Thomas GN, Tomlinson B. Chan P, et al. Acta Pharmacol Sin. 2002 Dec;23(12):1157-62. Acta Pharmacol Sin. 2002. PMID: 12466054 Free article. Review.

4

Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiontensin converting enzyme.

Liu JC, Hsu FL, Tsai JC, Chan P, Liu JY, Thomas GN, Tomlinson B, Lo MY, Lin JY. Liu JC, et al. Among authors: chan p. Life Sci. 2003 Aug 8;73(12):1543-55. doi: 10.1016/s0024-3205(03)00481-8. Life Sci. 2003. PMID: 12865094

5

The beneficial effects of Tai Chi Chuan on blood pressure and lipid profile and anxiety status in a randomized controlled trial.

Tsai JC, Wang WH, Chan P, Lin LJ, Wang CH, Tomlinson B, Hsieh MH, Yang HY, Liu JC. Tsai JC, et al. Among authors: chan p. J Altern Complement Med. 2003 Oct;9(5):747-54. doi: 10.1089/107555303322524599. J Altern Complement Med. 2003. PMID: 14629852 Clinical Trial.

6

Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study.

Hsieh MH, Chan P, Sue YM, Liu JC, Liang TH, Huang TY, Tomlinson B, Chow MS, Kao PF, Chen YJ. Hsieh MH, et al. Among authors: chan p. Clin Ther. 2003 Nov;25(11):2797-808. doi: 10.1016/s0149-2918(03)80334-x. Clin Ther. 2003. PMID: 14693305 Clinical Trial.

7

An update on the management of nephropathy in type 2 diabetes.

Zhao HL, Thomas GN, Leung W, Tomlinson B, Hsu YH, Chan P. Zhao HL, et al. Among authors: chan p. J Chin Med Assoc. 2003 Nov;66(11):627-36. J Chin Med Assoc. 2003. PMID: 14768849 Review.

8

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B. Thomas GN, et al. Among authors: chan p. Drugs Aging. 2006;23(2):131-55. doi: 10.2165/00002512-200623020-00004. Drugs Aging. 2006. PMID: 16536636 Review.

9

Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients.

Yang HY, Kao PF, Chen TH, Tomlinson B, Ko WC, Chan P. Yang HY, et al. Among authors: chan p. J Clin Pharmacol. 2007 Mar;47(3):397-403. doi: 10.1177/0091270006296762. J Clin Pharmacol. 2007. PMID: 17322151 Clinical Trial.

10

High risk sudden death patients with anomalous coronary arteries presented clinically with chest discomfort diagnosed by multi-detector computed tomographic angiography.

Zhang L, Liang Y, Pan H, Liu X, Lin Y, Liu Z, Chan P. Zhang L, et al. Among authors: chan p. Int J Cardiol. 2012 Jul 26;158(3):438-41. doi: 10.1016/j.ijcard.2012.04.130. Epub 2012 May 26. Int J Cardiol. 2012. PMID: 22633674 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,511 results

Search Page

Filters